A Study Comparing Brahmi churna and Sarpagandha churna for People with Early-Stage High Blood Pressure

EFFECT OF BRAHMI CHURNA IN COMPARISON WITH SARPAGANDHA CHURNA IN THE MANAGEMENT OF PRE-HYPERTENSION AND STAGE 1 ESSENTIAL HYPERTENSION : A RANDOMIZED CONTROLLED TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106604

Enrollment

Registered

2026-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with pre-hypertension and stage-1 Essential Hypertension. 2.Systolic blood pressure ranges between 120-159 mmhg and diastolic ranges between 80-99 mmhg 3.Patients aged between 30 yrs to 60 yrs irrespective of sex 4.Patients who are willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Secondary Hypertension ( associated with Diabetes Mellitus, Renal Failure, Neurological defects, Endocrinal disorders, etc. 2.Patients With Stage 2 Hypertension 3.Pregnent Women and Lactating Mothers

Design outcomes

Primary

Measure	Time frame
This study may provide an improvement in blood pressure levels in patients with pre-hypertension and stage-1 essential hypertension after treatment with Brahmi churna and Sarpagandha churna.Timepoint: follow up will be on 8th, 15th, 22nd, 30th days.	—

Secondary

Measure	Time frame
This study may provide Reduction in severity of associated symptoms (Shirshoola, Bhrama, Klamaa, Tandra, Hriddrava, Shwasa) after treatment.Timepoint: follow up will be on 8th, 15th, 22nd, 30th days.	—

Countries

India

Contacts

Public ContactDr Puja Haridasji Gabhane

Shri Ayurved Mahavidyalaya, Nagpur

mrityunjaysharma22@yahoo.co.in9373103182

Outcome results